Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Karyopharm Therapeutics (KPTI) Return on Assets (2016 - 2025)

Karyopharm Therapeutics (KPTI) has disclosed Return on Assets for 13 consecutive years, with 1.31% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets fell 80.0% year-over-year to 1.31%, compared with a TTM value of 1.31% through Dec 2025, down 80.0%, and an annual FY2025 reading of 0.03%, down 3.0% over the prior year.
  • Return on Assets was 1.31% for Q4 2025 at Karyopharm Therapeutics, up from 1.44% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.36% in Q1 2022 and bottomed at 1.44% in Q3 2025.
  • Average Return on Assets over 5 years is 0.63%, with a median of 0.53% recorded in 2021.
  • The sharpest move saw Return on Assets grew 26bps in 2022, then crashed -99bps in 2025.
  • Year by year, Return on Assets stood at 0.44% in 2021, then decreased by -26bps to 0.56% in 2022, then fell by 0bps to 0.56% in 2023, then rose by 9bps to 0.51% in 2024, then crashed by -156bps to 1.31% in 2025.
  • Business Quant data shows Return on Assets for KPTI at 1.31% in Q4 2025, 1.44% in Q3 2025, and 1.33% in Q2 2025.